Logo image of 1MARA.MI

MARA HOLDINGS INC (1MARA.MI) Stock Fundamental Analysis

BIT:1MARA - Euronext Milan - US5657881067 - Common Stock - Currency: EUR

12.936  +2.04 (+18.68%)

Fundamental Rating

3

Taking everything into account, 1MARA scores 3 out of 10 in our fundamental rating. 1MARA was compared to 97 industry peers in the Software industry. Both the profitability and financial health of 1MARA have multiple concerns. 1MARA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

1MARA had positive earnings in the past year.
1MARA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1MARA reported negative net income in multiple years.
1MARA had a negative operating cash flow in each of the past 5 years.
1MARA.MI Yearly Net Income VS EBIT VS OCF VS FCF1MARA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of 1MARA (12.92%) is better than 89.69% of its industry peers.
Looking at the Return On Equity, with a value of 21.27%, 1MARA belongs to the top of the industry, outperforming 84.54% of the companies in the same industry.
Industry RankSector Rank
ROA 12.92%
ROE 21.27%
ROIC N/A
ROA(3y)-12.16%
ROA(5y)-8.47%
ROE(3y)-49.6%
ROE(5y)-31.52%
ROIC(3y)N/A
ROIC(5y)N/A
1MARA.MI Yearly ROA, ROE, ROIC1MARA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

Looking at the Profit Margin, with a value of 106.92%, 1MARA belongs to the top of the industry, outperforming 97.94% of the companies in the same industry.
1MARA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 106.92%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1MARA.MI Yearly Profit, Operating, Gross Margins1MARA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

1MARA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1MARA has been increased compared to 1 year ago.
The number of shares outstanding for 1MARA has been increased compared to 5 years ago.
Compared to 1 year ago, 1MARA has a worse debt to assets ratio.
1MARA.MI Yearly Shares Outstanding1MARA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1MARA.MI Yearly Total Debt VS Total Assets1MARA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

1MARA has an Altman-Z score of 1.05. This is a bad value and indicates that 1MARA is not financially healthy and even has some risk of bankruptcy.
1MARA's Altman-Z score of 1.05 is on the low side compared to the rest of the industry. 1MARA is outperformed by 65.98% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that 1MARA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, 1MARA is not doing good in the industry: 68.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACCN/A
WACC9.49%
1MARA.MI Yearly LT Debt VS Equity VS FCF1MARA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

1MARA has a Current Ratio of 4.94. This indicates that 1MARA is financially healthy and has no problem in meeting its short term obligations.
1MARA's Current ratio of 4.94 is amongst the best of the industry. 1MARA outperforms 90.72% of its industry peers.
1MARA has a Quick Ratio of 4.94. This indicates that 1MARA is financially healthy and has no problem in meeting its short term obligations.
1MARA has a Quick ratio of 4.94. This is amongst the best in the industry. 1MARA outperforms 90.72% of its industry peers.
Industry RankSector Rank
Current Ratio 4.94
Quick Ratio 4.94
1MARA.MI Yearly Current Assets VS Current Liabilites1MARA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.64% over the past year.
The Revenue has grown by 112.02% in the past year. This is a very strong growth!
The Revenue has been growing by 252.85% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.7%
Revenue 1Y (TTM)112.02%
Revenue growth 3Y60.35%
Revenue growth 5Y252.85%
Sales Q2Q%36.76%

3.2 Future

The Earnings Per Share is expected to decrease by -33.38% on average over the next years. This is quite bad
1MARA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.26% yearly.
EPS Next Y-63.37%
EPS Next 2Y-38.96%
EPS Next 3Y-33.38%
EPS Next 5YN/A
Revenue Next Year51.65%
Revenue Next 2Y33.88%
Revenue Next 3Y25.61%
Revenue Next 5Y6.26%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1MARA.MI Yearly Revenue VS Estimates1MARA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
1MARA.MI Yearly EPS VS Estimates1MARA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.17, the valuation of 1MARA can be described as correct.
Based on the Price/Earnings ratio, 1MARA is valued cheaply inside the industry as 88.66% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1MARA to the average of the S&P500 Index (28.10), we can say 1MARA is valued slightly cheaper.
The Price/Forward Earnings ratio is 44.02, which means the current valuation is very expensive for 1MARA.
1MARA's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.74, 1MARA is valued quite expensively.
Industry RankSector Rank
PE 16.17
Fwd PE 44.02
1MARA.MI Price Earnings VS Forward Price Earnings1MARA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1MARA.MI Per share data1MARA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

1MARA's earnings are expected to decrease with -33.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.96%
EPS Next 3Y-33.38%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1MARA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARA HOLDINGS INC

BIT:1MARA (5/2/2025, 7:00:00 PM)

12.936

+2.04 (+18.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners61.19%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap4.47B
Analysts73.33
Price Target19.63 (51.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.06%
Min EPS beat(2)-61.41%
Max EPS beat(2)13.29%
EPS beat(4)2
Avg EPS beat(4)61.9%
Min EPS beat(4)-176.7%
Max EPS beat(4)472.43%
EPS beat(8)5
Avg EPS beat(8)322.73%
EPS beat(12)5
Avg EPS beat(12)118.56%
EPS beat(16)6
Avg EPS beat(16)40.09%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-14.9%
Max Revenue beat(2)12.77%
Revenue beat(4)2
Avg Revenue beat(4)22.03%
Min Revenue beat(4)-14.9%
Max Revenue beat(4)100.61%
Revenue beat(8)4
Avg Revenue beat(8)9.96%
Revenue beat(12)4
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-4.68%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)135.5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)223.29%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)2.81%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.49%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.17
Fwd PE 44.02
P/S 6.18
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)0.8
EY6.18%
EPS(NY)0.29
Fwd EY2.27%
FCF(TTM)-2.37
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS2.09
BVpS10.53
TBVpS10.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.92%
ROE 21.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 106.92%
GM N/A
FCFM N/A
ROA(3y)-12.16%
ROA(5y)-8.47%
ROE(3y)-49.6%
ROE(5y)-31.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.41%
Cap/Sales 30.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.94
Quick Ratio 4.94
Altman-Z 1.05
F-Score1
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)247.24%
Cap/Depr(5y)1644.95%
Cap/Sales(3y)163.79%
Cap/Sales(5y)566.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.7%
EPS Next Y-63.37%
EPS Next 2Y-38.96%
EPS Next 3Y-33.38%
EPS Next 5YN/A
Revenue 1Y (TTM)112.02%
Revenue growth 3Y60.35%
Revenue growth 5Y252.85%
Sales Q2Q%36.76%
Revenue Next Year51.65%
Revenue Next 2Y33.88%
Revenue Next 3Y25.61%
Revenue Next 5Y6.26%
EBIT growth 1Y-396.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.08%
EBIT Next 3Y37.51%
EBIT Next 5Y0.13%
FCF growth 1Y-171.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.48%
OCF growth 3YN/A
OCF growth 5YN/A